IJSRP Logo
International Journal of Scientific and Research Publications

IJSRP, Volume 4, Issue 12, December 2014 Edition [ISSN 2250-3153]
arrow Prostate Adenocarcinoma: are EGFR-targeted drugs of therapeutic relevance for castrate-resistant patients?
I. Sadaoui, V. Barrès, H. Amrani Hassani Joutei , N. El Gnaoui , W. Mahfoud, H. Benomar and S. Nadifi
Abstract: The progression of normal prostatic epithelium to androgen-dependent cancer and, eventually, castrate-resistant prostate cancer is a complex process involving many different growth regulatory signals. Activation of epidermal growth factor receptor (EGFR) has been implicated in prostate cancer cell growth.
CALL FOR PAPERS 2026

Submit your original research for the upcoming monthly edition.

SUBMIT MANUSCRIPT
PEER REVIEWED JOURNAL

High Impact & Global Indexing

Targeting Scopus Indexing 2026

Join 11,500+ Authors Globally

Publish Your Research Today
Reference this Research Paper (Copy):
I. Sadaoui, V. Barrès, H. Amrani Hassani Joutei , N. El Gnaoui , W. Mahfoud, H. Benomar and S. Nadifi (2014); Prostate Adenocarcinoma: are EGFR-targeted drugs of therapeutic relevance for castrate-resistant patients?; International Journal of Scientific and Research Publications (IJSRP) Volume 4, Issue 12 (ISSN: 2250-3153)
© Copyright 2011 - 2026 IJSRP Publications. All rights reserved.
| ISSN: 2250-3153 | DOI: 10.29322/IJSRP